Vericel Corp

VCEL

Market cap $1.82B

36.01 USD

-0.72

1.96%

At close Updated Dec 31, 4:00 PM EST

Pre-market

After hours

36.01

0.00

1 day

-1.96%

5 days

-3.25%

1 month

-7.24%

3 months

14.43%

6 months

-15.37%

Year to date

-34.66%

1 year

-34.42%

5 years

16.61%

10 years

1,295.74%

About: Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Employees: 357

Healthcare Biotechnology